Clinical and metabolic consequences of L-serine supplementation in hereditary sensory and autonomic neuropathy type 1C
Mari Auranen(University of Helsinki), Emil Ylikallio(University of Helsinki), Thorsten Hornemann(University Hospital of Zurich), Henna Tyynismaa(University of Helsinki), Saranya Suriyanarayanan(University Hospital Zurich), Anders Paetau(Helsinki University Hospital), Museer A. Lone(University of Zurich), Jussi Toppila(University of Helsinki)
Cited by 34
Related Papers
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386
A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1
|Nature Medicine|1998|349
Mitochondrial myopathy induces a starvation-like response
|Human Molecular Genetics|2010|306
Mitochondrial DNA Replication Defects Disturb Cellular dNTP Pools and Remodel One-Carbon Metabolism
|Cell Metabolism|2016|293